AMP-activated protein kinase in skeletal muscle: From structure and localization to its role as a master regulator of cellular metabolism

[1]  N. Fujii,et al.  Discovery of TBC1D1 as an Insulin-, AICAR-, and Contraction-stimulated Signaling Nexus in Mouse Skeletal Muscle* , 2008, Journal of Biological Chemistry.

[2]  D. Hardie,et al.  Normal hypertrophy accompanied by phosphoryation and activation of AMP‐activated protein kinase α1 following overload in LKB1 knockout mice , 2008, The Journal of physiology.

[3]  E. Dargelos,et al.  Calcium-dependent proteolytic system and muscle dysfunctions: a possible role of calpains in sarcopenia. , 2008, Biochimie.

[4]  D. Campbell,et al.  Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. , 2008, The Biochemical journal.

[5]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[6]  J. D. Brown,et al.  LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle. , 2007, American journal of physiology. Endocrinology and metabolism.

[7]  R. Chadwick,et al.  Tumor Necrosis Factor-α Augments Matrix Metalloproteinase-9 Production in Skeletal Muscle Cells through the Activation of Transforming Growth Factor-β-activated Kinase 1 (TAK1)-dependent Signaling Pathway , 2007 .

[8]  R. Heath,et al.  Defining the Mechanism of Activation of AMP-activated Protein Kinase by the Small Molecule A-769662, a Member of the Thienopyridone Family* , 2007, Journal of Biological Chemistry.

[9]  B. Viollet,et al.  Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase* , 2007, Journal of Biological Chemistry.

[10]  A. Tsuchida,et al.  Comparison of the antidiabetic effects of brain‐derived neurotrophic factor and thiazolidinediones in obese diabetic mice , 2007, Diabetes, obesity & metabolism.

[11]  U. Stochaj,et al.  Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK-->ERK1/2 pathway. , 2007, American journal of physiology. Cell physiology.

[12]  Perikles Simon,et al.  Upregulation of IL-6 mRNA by IL-6 in skeletal muscle cells: role of IL-6 mRNA stabilization and Ca2+-dependent mechanisms. , 2007, American journal of physiology. Cell physiology.

[13]  K. Nakashima,et al.  AMPK Activation Stimulates Myofibrillar Protein Degradation and Expression of Atrophy-Related Ubiquitin Ligases by Increasing FOXO Transcription Factors in C2C12 Myotubes , 2007, Bioscience, biotechnology, and biochemistry.

[14]  Y. Hellsten,et al.  Caffeine-induced Ca(2+) release increases AMPK-dependent glucose uptake in rodent soleus muscle. , 2007, American journal of physiology. Endocrinology and metabolism.

[15]  C. Lang,et al.  AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells. , 2007, American journal of physiology. Endocrinology and metabolism.

[16]  P. Schjerling,et al.  Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction. , 2007, American journal of physiology. Endocrinology and metabolism.

[17]  M. Czech,et al.  The GLUT4 glucose transporter. , 2007, Cell metabolism.

[18]  D. Carling,et al.  Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. , 2007, The Biochemical journal.

[19]  N. Fujii,et al.  CaMKK{alpha} regulates glucose uptake independent of AMPK and Akt signaling in mouse skeletal muscle , 2007 .

[20]  Miao Zhang,et al.  Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase* , 2007, Journal of Biological Chemistry.

[21]  B. Kemp,et al.  AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling , 2007, Circulation research.

[22]  Tao Pang,et al.  Conserved α-Helix Acts as Autoinhibitory Sequence in AMP-activated Protein Kinase α Subunits* , 2007, Journal of Biological Chemistry.

[23]  Su-Chang Lin,et al.  TAK1-dependent Signaling Requires Functional Interaction with TAB2/TAB3* , 2006, Journal of Biological Chemistry.

[24]  Michael D. Schneider,et al.  A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway , 2006, Proceedings of the National Academy of Sciences.

[25]  Uwe Riek,et al.  Dissecting the Role of 5′-AMP for Allosteric Stimulation, Activation, and Deactivation of AMP-activated Protein Kinase* , 2006, Journal of Biological Chemistry.

[26]  N. Fujii,et al.  AS160 Regulates Insulin- and Contraction-stimulated Glucose Uptake in Mouse Skeletal Muscle* , 2006, Journal of Biological Chemistry.

[27]  C. Kahn,et al.  Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3 , 2006, Molecular and Cellular Biology.

[28]  M. Carlson,et al.  Mammalian TAK1 Activates Snf1 Protein Kinase in Yeast and Phosphorylates AMP-activated Protein Kinase in Vitro* , 2006, Journal of Biological Chemistry.

[29]  N. Fujii,et al.  Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation. , 2006, American journal of physiology. Endocrinology and metabolism.

[30]  O. Gorelik,et al.  Total cellular calcium and magnesium content of cultured human peripheral blood mononuclear cells following exposure to antidiabetic drugs , 2006, Acta Diabetologica.

[31]  H. Westerblad,et al.  Role of reactive oxygen species in contraction‐mediated glucose transport in mouse skeletal muscle , 2006, The Journal of physiology.

[32]  N. LeBrasseur,et al.  Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. , 2006, American journal of physiology. Endocrinology and metabolism.

[33]  N. Fujii,et al.  Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle , 2006, Diabetes.

[34]  B. Viollet,et al.  AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits , 2006, Diabetes.

[35]  A. Goldberg,et al.  Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. , 2006, Journal of the American Society of Nephrology : JASN.

[36]  S. Gordon,et al.  Impaired overload‐induced muscle growth is associated with diminished translational signalling in aged rat fast‐twitch skeletal muscle , 2006, The Journal of physiology.

[37]  Kei Sakamoto,et al.  LKB1-dependent signaling pathways. , 2006, Annual review of biochemistry.

[38]  L. Kifle,et al.  Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. , 2006, Cell metabolism.

[39]  K. Nakao,et al.  Low-intensity contraction activates the alpha1-isoform of 5'-AMP-activated protein kinase in rat skeletal muscle. , 2006, American journal of physiology. Endocrinology and metabolism.

[40]  M. Febbraio,et al.  Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle. , 2006, American journal of physiology. Endocrinology and metabolism.

[41]  K. Fukunaga,et al.  Prominent expression and activity‐dependent nuclear translocation of Ca2+/calmodulin‐dependent protein kinase Iδ in hippocampal neurons , 2005, The European journal of neuroscience.

[42]  N. Fujii,et al.  AMP-activated Protein Kinase α2 Activity Is Not Essential for Contraction- and Hyperosmolarity-induced Glucose Transport in Skeletal Muscle* , 2005, Journal of Biological Chemistry.

[43]  D. Taillandier,et al.  Lysosomal proteolysis in skeletal muscle. , 2005, The international journal of biochemistry & cell biology.

[44]  C. Bruce,et al.  AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle , 2005, The Journal of physiology.

[45]  Kei Sakamoto,et al.  Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction , 2005, The EMBO journal.

[46]  Joseph Avruch,et al.  Rheb Binds and Regulates the mTOR Kinase , 2005, Current Biology.

[47]  S. Gordon,et al.  Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation. , 2005, Journal of applied physiology.

[48]  E. Taylor,et al.  Endurance training increases LKB1 and MO25 protein but not AMP-activated protein kinase kinase activity in skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.

[49]  B. Viollet,et al.  The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. , 2004, Diabetes.

[50]  Bente Kiens,et al.  Regulation of hormone‐sensitive lipase activity and Ser563 and Ser565 phosphorylation in human skeletal muscle during exercise , 2004, The Journal of physiology.

[51]  G. Hjälm,et al.  The 5′-AMP-activated Protein Kinase γ3 Isoform Has a Key Role in Carbohydrate and Lipid Metabolism in Glycolytic Skeletal Muscle* , 2004, Journal of Biological Chemistry.

[52]  D. Hardie,et al.  Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. , 2004, American journal of physiology. Endocrinology and metabolism.

[53]  B. Pedersen,et al.  AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. , 2004, Biochemical and biophysical research communications.

[54]  K. Nakao,et al.  Possible involvement of the alpha1 isoform of 5'AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.

[55]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[56]  J. Wojtaszewski,et al.  Regulation of glycogen synthase activity and phosphorylation by exercise , 2004, The Proceedings of the Nutrition Society.

[57]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[58]  H. Galbo,et al.  Contractions induce phosphorylation of the AMPK site Ser565 in hormone-sensitive lipase in muscle. , 2004, Biochemical and biophysical research communications.

[59]  N. Dale,et al.  AICA riboside both activates AMP‐activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus , 2004, Journal of neurochemistry.

[60]  P. Cohen,et al.  TAB3, a new binding partner of the protein kinase TAK1. , 2004, The Biochemical journal.

[61]  B. Kemp.  Bateman domains and adenosine derivatives form a binding contract. , 2004, The Journal of clinical investigation.

[62]  D. Hardie,et al.  CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. , 2004, The Journal of clinical investigation.

[63]  Peter Schjerling,et al.  Knockout of the α2 but Not α1 5′-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle* , 2004, Journal of Biological Chemistry.

[64]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[65]  L. Cantley,et al.  Rheb fills a GAP between TSC and TOR. , 2003, Trends in biochemical sciences.

[66]  Hans Clevers,et al.  MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm , 2003 .

[67]  D. Hardie,et al.  Elm1p Is One of Three Upstream Kinases for the Saccharomyces cerevisiae SNF1 Complex , 2003, Current Biology.

[68]  David Carling,et al.  Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[69]  H C Clevers,et al.  Activation of the tumour suppressor kinase LKB1 by the STE20‐like pseudokinase STRAD , 2003, The EMBO journal.

[70]  R. McCartney,et al.  Yeast Pak1 Kinase Associates with and Activates Snf1 , 2003, Molecular and Cellular Biology.

[71]  J. James,et al.  A Novel Domain in AMP-Activated Protein Kinase Causes Glycogen Storage Bodies Similar to Those Seen in Hereditary Cardiac Arrhythmias , 2003, Current Biology.

[72]  B. Kemp,et al.  AMPK β Subunit Targets Metabolic Stress Sensing to Glycogen , 2003, Current Biology.

[73]  I. Muraoka,et al.  Changes in [Ca2+]i induced by several glucose transport-enhancing stimuli in rat epitrochlearis muscle. , 2003, Journal of applied physiology.

[74]  John M Asara,et al.  Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation* , 2003, The Journal of Biological Chemistry.

[75]  R. Brownsey,et al.  5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[76]  B. Kemp,et al.  Exercise increases nuclear AMPK α2 in human skeletal muscle , 2003 .

[77]  D. Carling,et al.  Protein kinase inhibitors block the stimulation of the AMP‐activated protein kinase by 5‐amino‐4‐imidazolecarboxamide riboside , 2002, FEBS letters.

[78]  B. Saltin,et al.  Dissociation of AMPK activity and ACCbeta phosphorylation in human muscle during prolonged exercise. , 2002, Biochemical and biophysical research communications.

[79]  D. Vertommen,et al.  Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis , 2002, Current Biology.

[80]  D. Hardie,et al.  The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. , 2002, Diabetes.

[81]  David Carling,et al.  The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[82]  D. Bolster,et al.  AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling* , 2002, The Journal of Biological Chemistry.

[83]  W. Winder,et al.  Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. , 2002, Journal of applied physiology.

[84]  T. Naka,et al.  The paradigm of IL-6: from basic science to medicine , 2002, Arthritis research.

[85]  P. Roach,et al.  Glycogen and its metabolism. , 2002, Current molecular medicine.

[86]  P. Neufer,et al.  Transcriptional activation of the IL‐6 gene in human contracting skeletal muscle: influence of muscle glycogen content , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[87]  H. Tokumitsu,et al.  Differential regulatory mechanism of Ca2+/calmodulin-dependent protein kinase kinase isoforms. , 2001, Biochemistry.

[88]  M. Reid,et al.  Detection of reactive oxygen and reactive nitrogen species in skeletal muscle , 2001, Microscopy research and technique.

[89]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[90]  J. Ninomiya-Tsuji,et al.  An Evolutionarily Conserved Motif in the TAB1 C-terminal Region Is Necessary for Interaction with and Activation of TAK1 MAPKKK* , 2001, The Journal of Biological Chemistry.

[91]  G. Sapkota,et al.  Phosphorylation of the Protein Kinase Mutated in Peutz-Jeghers Cancer Syndrome, LKB1/STK11, at Ser431 by p90RSK and cAMP-dependent Protein Kinase, but Not Its Farnesylation at Cys433, Is Essential for LKB1 to Suppress Cell Growth* , 2001, The Journal of Biological Chemistry.

[92]  B. Kemp,et al.  Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. , 2001, The Biochemical journal.

[93]  J. Ninomiya-Tsuji,et al.  Regulation of the TAK1 Signaling Pathway by Protein Phosphatase 2C* , 2001, The Journal of Biological Chemistry.

[94]  M. Birnbaum,et al.  Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'. , 2001, Biochemical Society transactions.

[95]  W. Winder,et al.  Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated. , 2000, Journal of applied physiology.

[96]  M. Owen,et al.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.

[97]  J. Mizukami,et al.  Phosphorylation‐dependent activation of TAK1 mitogen‐activated protein kinase kinase kinase by TAB1 , 2000, FEBS letters.

[98]  C. Rogel-Gaillard,et al.  A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. , 2000, Science.

[99]  N. Fujii,et al.  Activation of AMP-Activated Protein Kinase as a Unifying Coupling Mechanism , 2000 .

[100]  K. Irie,et al.  TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. , 2000, Molecular cell.

[101]  D. Carling,et al.  Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. , 2000, The Biochemical journal.

[102]  J. Ninomiya-Tsuji,et al.  TAK1 Mitogen-activated Protein Kinase Kinase Kinase Is Activated by Autophosphorylation within Its Activation Loop* , 2000, The Journal of Biological Chemistry.

[103]  M. Rigoulet,et al.  Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* , 2000, The Journal of Biological Chemistry.

[104]  C. Kahn,et al.  Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. , 1999, The Journal of clinical investigation.

[105]  B. Kemp,et al.  Expression of the AMP‐activated protein kinase β1 and β2 subunits in skeletal muscle , 1999 .

[106]  R. Anderson,et al.  Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve‐week, randomized, placebo‐controlled study , 1999, Diabetes, obesity & metabolism.

[107]  B. Kemp,et al.  Cellular Distribution and Developmental Expression of AMP‐Activated Protein Kinase Isoforms in Mouse Central Nervous System , 1999, Journal of neurochemistry.

[108]  B. Kemp,et al.  Functional Domains of the α1 Catalytic Subunit of the AMP-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.

[109]  A. Edelman,et al.  Components of a Calmodulin-dependent Protein Kinase Cascade , 1998, The Journal of Biological Chemistry.

[110]  G. Merrill,et al.  Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle. , 1998, Journal of applied physiology.

[111]  A. Prescott,et al.  AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. , 1998, The Biochemical journal.

[112]  Tatsuya Hayashi,et al.  Evidence for 5′AMP-Activated Protein Kinase Mediation of the Effect of Muscle Contraction on Glucose Transport , 1998, Diabetes.

[113]  C. Thornton,et al.  Identification of a Novel AMP-activated Protein Kinase β Subunit Isoform That Is Highly Expressed in Skeletal Muscle* , 1998, The Journal of Biological Chemistry.

[114]  H. Sakagami,et al.  Localization of the mRNAs for two isoforms of Ca2+/calmodulin-dependent protein kinase kinases in the adult rat brain. , 1998, Brain research. Molecular brain research.

[115]  K. Yanagisawa,et al.  Molecular cloning of human TAK1 and its mutational analysis in human lung cancer , 1998, International journal of cancer.

[116]  K. Sahlin,et al.  Energy supply and muscle fatigue in humans. , 1998, Acta physiologica Scandinavica.

[117]  Alexei F. Kisselev,et al.  Range of Sizes of Peptide Products Generated during Degradation of Different Proteins by Archaeal Proteasomes* , 1998, The Journal of Biological Chemistry.

[118]  Tatsuya Hayashi,et al.  Exercise regulation of glucose transport in skeletal muscle. , 1997, The American journal of physiology.

[119]  D. Hardie,et al.  AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, The American journal of physiology.

[120]  D. Hardie,et al.  AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, American journal of physiology. Endocrinology and metabolism.

[121]  C. Pickart.  Targeting of substrates to the 26S proteasome , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[122]  B. Kemp,et al.  Posttranslational Modifications of the 5′-AMP-activated Protein Kinase β1 Subunit* , 1997, The Journal of Biological Chemistry.

[123]  H. Fujisawa,et al.  Molecular cloning of Ca2+/calmodulin-dependent protein kinase kinase beta. , 1997, Journal of biochemistry.

[124]  D. Power,et al.  AMP‐activated protein kinase isoenzyme family: subunit structure and chromosomal location , 1997, FEBS letters.

[125]  Alexei F. Kisselev,et al.  Processive Degradation of Proteins and Other Catalytic Properties of the Proteasome from Thermoplasma acidophilum* , 1997, The Journal of Biological Chemistry.

[126]  D. Hardie,et al.  The α1 and α2 isoforms of the AMP‐activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro , 1996 .

[127]  S. Hawley,et al.  Characterization of the AMP-activated Protein Kinase Kinase from Rat Liver and Identification of Threonine 172 as the Major Site at Which It Phosphorylates AMP-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[128]  M. Erion,et al.  Hypoglycaemic effect of AICAriboside in mice , 1996, Diabetologia.

[129]  Bruce E. Kemp,et al.  Regulation of 5′-AMP-activated Protein Kinase Activity by the Noncatalytic β and γ Subunits* , 1996, The Journal of Biological Chemistry.

[130]  K. Irie,et al.  TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction , 1996, Science.

[131]  A. Edelman,et al.  Multiple Ca-Calmodulin-dependent Protein Kinase Kinases from Rat Brain , 1996, The Journal of Biological Chemistry.

[132]  J. Scott,et al.  Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. , 1996, The Journal of biological chemistry.

[133]  T. Soderling,et al.  Requirements for Calcium and Calmodulin in the Calmodulin Kinase Activation Cascade (*) , 1996, The Journal of Biological Chemistry.

[134]  B. Kemp,et al.  Mammalian AMP-activated Protein Kinase Subfamily (*) , 1996, The Journal of Biological Chemistry.

[135]  D. Hardie,et al.  5′‐AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP‐activated protein kinase. Studies using bacterially expressed human protein phosphatase‐2Cα and native bovine protein phosphatase‐2Ac , 1995, FEBS letters.

[136]  A. Edelman,et al.  5′-AMP Activates the AMP-activated Protein Kinase Cascade, and Ca2+/Calmodulin Activates the Calmodulin-dependent Protein Kinase I Cascade, via Three Independent Mechanisms (*) , 1995, The Journal of Biological Chemistry.

[137]  T. Soderling,et al.  Characterization of a Ca2+/Calmodulin-dependent Protein Kinase Cascade , 1995, The Journal of Biological Chemistry.

[138]  D. Hardie,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[139]  J. Holloszy,et al.  Wortmannin inhibits insulin‐stimulated but not contraction‐stimulated glucose transport activity in skeletal muscle , 1995, FEBS letters.

[140]  M. Birnbaum,et al.  The Effects of Wortmannin on Rat Skeletal Muscle , 1995, The Journal of Biological Chemistry.

[141]  B. Kemp,et al.  Mammalian 5'-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. , 1994, The Journal of biological chemistry.

[142]  J. Scott,et al.  Yeast SNF1 is functionally related to mammalian AMP-activated protein kinase and regulates acetyl-CoA carboxylase in vivo. , 1994, The Journal of biological chemistry.

[143]  T. Haystead,et al.  Purification of the AMP-activated protein kinase on ATP-gamma-sepharose and analysis of its subunit structure. , 1994, European journal of biochemistry.

[144]  B. Kemp,et al.  Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. , 1994, The Journal of biological chemistry.

[145]  D. Hardie,et al.  The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. , 1989, Biochimica et biophysica acta.

[146]  D. Hardie,et al.  Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. , 1988, European journal of biochemistry.

[147]  David Carling,et al.  A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis , 1987, FEBS letters.

[148]  M. Carlson,et al.  A yeast gene that is essential for release from glucose repression encodes a protein kinase. , 1986, Science.

[149]  F. Hegardt,et al.  Activation of rat liver cytosolic 3-hydroxy-3-methylglutaryl coenzyme A reductase kinase by adenosine 5'-monophosphate. , 1985, Biochemical and biophysical research communications.

[150]  E. Holmes,et al.  5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells. , 1985, The Journal of biological chemistry.

[151]  A. Haas,et al.  The mechanism of ubiquitin activating enzyme. A kinetic and equilibrium analysis. , 1982, The Journal of biological chemistry.

[152]  K. Kim,et al.  Regulation of rat liver acetyl-CoA carboxylase. Regulation of phosphorylation and inactivation of acetyl-CoA carboxylase by the adenylate energy charge. , 1980, The Journal of biological chemistry.

[153]  N. Fujii,et al.  Discovery of TBC 1 D 1 as an Insulin-, AICAR-, and Contraction-stimulated Signaling Nexus in Mouse Skeletal Muscle * , 2008 .

[154]  C. Lang,et al.  AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF 1 in C 2 C 12 cells , 2007 .

[155]  Bente Kiens,et al.  Skeletal muscle lipid metabolism in exercise and insulin resistance. , 2006, Physiological reviews.

[156]  N. Ruderman,et al.  Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. , 2005, American journal of physiology. Endocrinology and metabolism.

[157]  B. Kemp,et al.  AMP-activated protein kinase beta subunit tethers alpha and gamma subunits via its C-terminal sequence (186-270). , 2005, The Journal of biological chemistry.

[158]  B. Viollet,et al.  Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. , 2004, The Journal of biological chemistry.

[159]  B. Kemp,et al.  Exercise increases nuclear AMPK alpha2 in human skeletal muscle. , 2003, Diabetes.

[160]  B. Kemp,et al.  AMPK beta subunit targets metabolic stress sensing to glycogen. , 2003, Current biology : CB.

[161]  A. Goldberg,et al.  Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.

[162]  S. Taylor,et al.  The catalytic subunit of cAMP-dependent protein kinase: prototype for an extended network of communication. , 1999, Progress in biophysics and molecular biology.

[163]  B. Kemp,et al.  Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle. , 1999, FEBS letters.

[164]  L. Goodyear,et al.  Exercise, glucose transport, and insulin sensitivity. , 1998, Annual review of medicine.

[165]  M. Glickman,et al.  Copyright © 1998, American Society for Microbiology The Regulatory Particle of the Saccharomyces cerevisiae Proteasome , 1997 .

[166]  A. Edelman,et al.  Multiple Ca(2+)-calmodulin-dependent protein kinase kinases from rat brain. Purification, regulation by Ca(2+)-calmodulin, and partial amino acid sequence. , 1996, Journal of Biological Chemistry.

[167]  J. Scott,et al.  The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. , 1996, FEBS letters.

[168]  K. Irie,et al.  TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. , 1996, Science.

[169]  R. Colbran,et al.  Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. , 1989, European journal of biochemistry.

[170]  B. Pedersen,et al.  Immunohistochemical detection of interleukin‐6 in human skeletal muscle fibers following exercise , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[171]  G. Sapkota,et al.  Identification and characterization of four novel phosphorylation sites (Ser 31 , Ser 325 , Thr 336 and Thr 366 ) on LKB1/STK11, the protein kinase mutated in Peutz–Jeghers cancer syndrome , 2022 .